Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC] - N0000193913
Pharmacologic Class Information
Pharmacologic Code | N0000193913 |
Pharmacologic Name | Adenosine Triphosphate-Citrate Lyase Inhibitor |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Adenosine Triphosphate-Citrate Lyase Inhibitor
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
72426-818 | Nexlizet | Non-Proprietary Name: Bempedoic Acid And Ezetimibe | Tablet, Film Coated | Oral | Esperion Therapeutics, Inc. | ACTIVE | |
72426-118 | Nexletol | Non-Proprietary Name: Bempedoic Acid | Tablet, Film Coated | Oral | Esperion Therapeutics, Inc. | ACTIVE |